Cellyan Biotechnology Co., Ltd
About Cellyan Biotechnology Co., Ltd
Cellyan Biotechnology Co Ltd formerly, Hong Kong Pharma Digital Technology Holdings Ltd operates in two main categories: OTC pharmaceutical cross-border e-commerce supply chain services, conducted through its Hong Kong subsidiary, Joint Cross Border, which it refers to as the Supply Chain Services division, and OTC pharmaceutical cross-border procurement and distribution, conducted through its Hong Kong subsidiary, V-Alliance, which it referred to as the Procurement and Distribution division. Based in Hong Kong, Joint Cross Border has established itself as a provider of third-party supply chain services in Mainland China's OTC pharmaceutical cross-border e-commerce market.
This profile is unclaimed. An authorized representative can claim it to add details and earn the Verified badge.
Financial summary
- Market cap
- $11.6M
15-minute delayed · data by Polygon.io
Past year
52-week range
- Market cap
- $11.6M
- Shares outstanding
- 25.8M
- Open
- —
- Day range
- –
- Prev close
- —
- Volume
- —
- IPO date
- Jan 15, 2025
Market data by Polygon.io · prices are 15-minute delayed
At a glance
- Trading 79% below its 52-week high.
Automatically generated from public filings and market data. Informational only — not investment advice or a recommendation to buy or sell any security.
No reviews yet. Be the first to review Cellyan Biotechnology Co., Ltd.
Write a review
News about Cellyan Biotechnology Co., Ltd
News & sentiment via Polygon.io
